GLP-1 based drugs are transforming the treatment of obesity and opening up new avenues for addressing heart disease, ...

This analysis finds that 57.4 million adults under the age of 65 could potentially be eligible for GLP-1 drugs based on ...

Starting price of $149 offers improved accessibility compared to market prices of brand-name medications which can be 8x ...

The demand for medications like Ozempic continues to cause shortages for both those seeking weight loss and patients with ...

Hims & Hers, the telehealth company, saw its stock price range from under $6 to over $25 during the last 52 weeks. Click here ...

There is soaring demand for weight-loss drugs in the GLP-1 class, and the company will now sell it to certain professions for ...

A large swath of insured Americans could be eligible for a popular class of weight loss and diabetes drugs. Meanwhile, Apple ...

The popularity of the newest weight loss medications has employers reevaluating their health plans. There are a lot of unknowns, but here’s what we do know based on the data.

Kourtney Kardashian just launched an herbal supplement called GLP-1 Daily. GLP-1 drugs like Ozempic and Wegovy are FDA-approved for diabetes and weight-loss. Wellness brands are scrambling to ...

The plaintiffs' attorneys claim that GLP-1 drugs — specifically Ozempic ... the litigation against the pharmaceutical giants, 85% list gastroparesis as an alleged injury. Gastroparesis occurs ...

Karla Robinson, MD and Medical Editor at GoodRx discusses how GLP-1 receptor agonists work and their benefits.

While drugmakers Novo Nordisk and Eli Lilly assert that shortages of popular weight loss and diabetes medications Wegovy, Ozempic, Mounjaro and Zepbound are easing, many patients continue to face ...